CIK 0001761918 · <br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- 4 Other acquisition General Counsel & Corp. Sec. acquired 5,448 shares (other)
- 4 Open-market buy Director bought 10,000 shares at $1.85 ($18,480)
- 4 Open-market buy Chairman & CEO bought 1,000,000 shares at an average $1.70 ($1,696,179)
- 4 Open-market buy Director bought 30,000 shares at $1.66 ($49,785)
- 4 Open-market buy Chairman & CEO bought 1,000,000 shares at $2.03 ($2,026,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chairman & CEO bought 100,000 shares at $2.75 ($275,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $2.76 ($55,230)
- 4 Open-market buy Chairman & CEO bought 100,000 shares at $2.84 ($284,000)
- 5 Insider Annual Insider Trading Report
Page 4 of 7 · 127 filings